Gossamer Bio, Inc. (GOSS)
10.97
-0.27
(-2.40%)
USD |
NASDAQ |
Nov 13, 16:00
10.92
-0.05
(-0.46%)
After-Hours: 19:59
Gossamer Bio Gross Profit Margin (Quarterly) : 99.41% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.41% |
| June 30, 2026 | 97.27% |
| March 31, 2026 | 98.63% |
| December 31, 2025 | 98.36% |
| September 30, 2025 | 98.35% |
| Date | Value |
|---|---|
| June 30, 2025 | 98.15% |
| March 31, 2025 | 96.54% |
| December 31, 2024 | 88.54% |
| September 30, 2024 | 88.59% |
| June 30, 2024 | 98.96% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| United Therapeutics Corp. | 88.10% |
| Arbutus Biopharma Corp. | 96.66% |
| ACADIA Pharmaceuticals, Inc. | 89.75% |
| Alnylam Pharmaceuticals, Inc. | 75.19% |
| Anika Therapeutics, Inc. | 61.57% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -96.04% |
| Return on Invested Capital | -588.7% |
| Profit Margin (Quarterly) | -125.1% |
| Operating Margin (Quarterly) | 25.93% |
| Return on Net Operating Assets | -1.10K% |